Market
Scenario
The cell
isolation market is expected to gain prominence over the forecast period
(2018–2023). It is estimated that the cell isolation market is expected to grow
at a CAGR ~17.8 % during the forecast period of 2018–2023.
Cell
isolation is the process of separating individual living cells from a cluster
of tissue or cell suspension. It may be used for volume reduction of
blood components, recovery of mononucleated cells from cord blood, the
concentration of bone marrow, and other cell isolation applications.
The market growth is mainly attributed to the
increasing prevalence of cancer and infectious diseases and rising government
funding for cell-based research. For instance, in 2015, the National Institutes
of Health invested around 1,429 million USD for stem cells research. Moreover,
technological advancements, growing research on personalized medicine and
increasing demand for biopharmaceuticals is likely to contribute to the market
growth during the forecast period. Despite the drivers, the high cost of cell
isolation systems and complex cell behavior characteristics restrains the
growth of the market.
Segmentation
The cell
isolation market is segmented on the basis of product, cell type, technique,
application, and end-user.
On the
basis of the product, the market is classified as consumables and instruments.
The consumables are further classified as reagents, kits, media, and sera,
beads, disposables. The instruments are segmented into centrifuges, flow
cytometers, magnetic-activated cell separation, and filtration system. The
magnetic-activated cell separator system is further classified into manual
magnetic-activated cell separator systems and automated magnetic-activated cell
separator systems.
On the
basis of cell type, the market is segmented into human cells and animal cells.
The human cells are further segmented into differentiated cells and stem cells.
The cell
isolation market on the basis of the technique is segmented as
centrifugation-based cell isolation, surface marker-based cell isolation, and
filtration-based cell isolation.
On the
basis of the application, the market is segmented into biomolecule isolation,
cancer research, stem cell research, tissue regeneration, in vitro diagnostics,
and therapeutics.
On the
basis of the end-user, the market is segmented as research laboratories and
institutes, hospitals and diagnostic laboratories, cell banks, biotechnology
and biopharmaceutical companies.
Geographically,
cell isolation market has been segmented into America, Europe, Asia-Pacific,
and the Middle East & Africa. The Americas cell isolation market is further
segmented into North America, and South America. North America is further
classified as the US and Canada.
The
European cell isolation market is segmented into Western Europe and Eastern
Europe. Western Europe is further classified as Germany, France, the UK, Italy,
Spain, and the Rest of Western Europe.
The
Asia-Pacific cell isolation market is segmented into Japan, China, India,
Republic of Korea, Australia, and the Rest of Asia-Pacific.
The
Middle Eastern and African cell isolation market is segmented into the Middle
East and Africa.
Regional Market
Summary
The
American region is expected to dominate the cell isolation market, owing to the
existing well-established healthcare system, increasing prevalence of cancer
cases, increasing government funding in research, and technological
advancements. According to the National Cancer Institute, in 2016, around
1,685,210 new cases of cancer had been diagnosed in the US Furthermore, the
increasing cancer care expenditure in the United States is likely to drive the
market growth. For instance, in 2017, the US Department of Health and Human
Services estimated 147.3 billion USD national expenditures for cancer care.
Europe is
anticipated to hold the second position in the cell isolation market. It is
expected that the government support towards research & development
expenditure and rising prevalence chronic diseases such as cancer is likely to
drive the European cell isolation market. According to the Cancer
Research UK, in 2012, 14.1 million cases of cancer were diagnosed all over the
world, and 8.2 million died due to cancer. It also projected that the number of
cancer patients is expected to reach 23.6 million in 2030.
The
Asia-Pacific cell isolation market consists of countries namely China, Japan,
Republic of Korea, India, and Australia. The market growth is mainly driven by
rapidly expanding biopharmaceutical industries in the region and rising
government funding in life sciences sector. Moreover, countries like India and
China have established research institutes promoting cell-based research which contributes
to the market growth.
The
Middle East & Africa holds the lowest share of the global market due to low
development, lack of technical knowledge, and poor medical facilities.
Company
Profiles
- Beckman
Coulter (Subsidiary of Danaher Corporation)
- Becton,
Dickinson, and Company
- GE
Healthcare (A Fully Owned Subsidiary of General Electric Company)
- Merck
KGaA
- Thermo
Fisher Scientific Inc.
- Miltenyi
Biotec
- Pluriselect
Life Science
- Stemcell
Technologies Inc.
- Terumo
Bct (A Subsidiary of Terumo Corporation)
- Bio-Rad
Laboratories, Inc.
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com